The Study Start-up accelerator enables Life Sciences companies to leverage a BPM, Case Management and Low-code platform to automate and organize the Clinical Study Start-up process across the globe.
Create your own Study Start-up solution using this accelerator.
Study Start-up made easy
One of the key challenges faced by any global Life Sciences company is keeping up with and adapting to the amount of change and variation in regulatory requirements around the world. The Study Start-up accelerator provides a way to automate the clinical study start-up process from end-to-end, providing rich user experience, flexible workflow and deep insight into the process execution into the tasks orchestrated across sites spread across the globe.
For a Life Sciences company, when a new drug is ready to be included in a clinical trial, a fairly complicated regulatory process is followed to get the study sites ready. The Study Start-up accelerator orchestrates the internal collaboration of the regulatory process for circulating the new drug to various sites where it can be administered within the trial according to the Local Regulatory Health Authority.